Intranasal Insulin for Weight Management During Smoking Cessation

NCT02028871 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Tobacco Abstinence Syndrome

Interventions

DRUG: Intranasal Insulin
DRUG: Placebo

Sponsor

Ajna Hamidovic